The digital health sector emerged as a juggernaut during the COVID-19 pandemic, with almost $15 billion invested in privately-held digital health companies in 2020 and nearly $30 billion invested last year, according to our...more
2/14/2022
/ Capital Markets ,
Digital Health ,
Emerging Technology Companies ,
Initial Public Offering (IPO) ,
Investment ,
Investment Opportunities ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Startups ,
Telehealth ,
Venture Capital
At the end of Q3, aggregate funding raised by digital health startups in 2021 surpassed $20 billion. Although 2021 continues to be a record-breaking year for digital health startups, investors gently tapped the breaks in Q3....more
11/24/2021
/ Capital Raising ,
Clinical Trials ,
Digital Health ,
Financing ,
Health Information Technologies ,
Healthcare ,
Initial Public Offering (IPO) ,
Investment ,
Life Sciences ,
Medical Devices ,
Mental Health ,
Pharmaceutical Industry ,
Startups ,
Telemedicine
The annual gathering of life sciences executives and investors in San Francisco that many now call “JPM Week” recently concluded, marking the J.P. Morgan Healthcare Conference’s 38th year....more
1/24/2020
/ Biosimilars ,
Biotechnology ,
Bristol-Myers Squibb ,
China ,
Digital Health ,
Genetic Materials ,
Genetic Testing ,
Investment ,
Investment Opportunities ,
JPMorgan Chase ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
UK Brexit ,
US Trade Policies ,
Venture Capital
Fenwick’s eighth annual Digital Health Investor Summit took place against the backdrop of strong and increasingly diverse investment markets, a focus on clinical validation of digital health tools, and a healthcare system...more
11/21/2019
/ Digital Health ,
Emerging Technology Companies ,
Initial Public Offering (IPO) ,
Investment ,
Investment Opportunities ,
Life Sciences ,
Medical Devices ,
Pharmaceutical Industry ,
Startups ,
Telehealth ,
Venture Capital
Just over a year ago, we reported about the rise of the mega-round in digital health investments. At that time, we tallied nine investment rounds valued at more than $100 million in the first half of 2017. ...more
Two trends stood out in our analysis of private digital health investments in the first quarter of 2018: bigger deals and more investment in companies targeting the regulated portion of the health care market....more
Investors are increasingly interested in companies with technologies that will be subject to U.S. Food and Drug Administration (FDA) regulation.
Until recently, some investors shied away from companies targeting the...more
Our fourth annual Digital Health Summit brought together a select group of investors active in the digital health, life sciences, medical device, and healthcare industries for a one-day meeting to discuss the future of...more
9/1/2015
/ ACOs ,
Bundled Payments ,
Digital Health ,
Fee-for-Service ,
Health Care Providers ,
Healthcare ,
Investors ,
Life Sciences ,
Medical Devices ,
Patients ,
Pharmaceutical Industry ,
Popular ,
Qualcomm ,
Telemedicine ,
Value-Based Fees
Digital health investors seem to have taken a step back to catch their breath in November after 10 months of record-breaking activity. There were only 6 investments in November of $10 million or more and only one for more...more
With venture capital funding of digital health up 45 percent in 2012, according to Rock Health, we’re hearing a lot about mobile health apps and healthcare IT. You may be asking yourself what is digital health? Michael...more
As CES 2013 draws to a close, Michael Esquivel, a partner in Fenwick’s Start-ups and Venture Capital Group, identifies where the action is for entrepreneurs and investors in digital health and healthcare IT. According to...more